Function in a Human Melanoma Model MHC Class I-Restricted Cytolytic Effector TCR Synthesize Th 1 Cytokines and Exhibit MHC Class I-Restricted Epitope-Specific T Cells Transduced to Express − CD 25 + CD 4 Baltimore and Bijay Mukherji

[1]  A. Chhabra,et al.  Silencing of endogenous IL-10 in human dendritic cells leads to the generation of an improved CTL response against human melanoma associated antigenic epitope, MART-1 27-35. , 2008, Clinical immunology.

[2]  T. Schumacher,et al.  Generation of T Cell Help through a MHC Class I-Restricted TCR1 , 2006, The Journal of Immunology.

[3]  H. Ikeda,et al.  Generation of tumor-specific, HLA class I-restricted human Th1 and Tc1 cells by cell engineering with tumor peptide-specific T-cell receptor genes. , 2005, Blood.

[4]  S. Xue,et al.  A critical role of T cell antigen receptor-transduced MHC class I-restricted helper T cells in tumor protection , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Richard A. Morgan,et al.  Primary Human Lymphocytes Transduced with NY-ESO-1 Antigen-Specific TCR Genes Recognize and Kill Diverse Human Tumor Cell Lines , 2005, The Journal of Immunology.

[6]  S. Mehrotra,et al.  Rescuing Melanoma Epitope-Specific Cytolytic T Lymphocytes from Activation-Induced Cell Death, by SP600125, an Inhibitor of JNK: Implications in Cancer Immunotherapy1 , 2004, The Journal of Immunology.

[7]  S. Mehrotra,et al.  Cross‐presentation of a human tumor antigen delivered to dendritic cells by HSV VP22‐mediated protein translocation , 2004, European journal of immunology.

[8]  S. Rosenberg,et al.  Cancer immunotherapy: moving beyond current vaccines , 2004, Nature Medicine.

[9]  M. Bevan.  Helping the CD8+ T-cell response , 2004, Nature Reviews Immunology.

[10]  J. Blattman,et al.  Cancer Immunotherapy: A Treatment for the Masses , 2004, Science.

[11]  Smaroula Dilioglou,et al.  Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide–based retroviral vector , 2004, Nature Biotechnology.

[12]  S. Rosenberg,et al.  High Efficiency TCR Gene Transfer into Primary Human Lymphocytes Affords Avid Recognition of Melanoma Tumor Antigen Glycoprotein 100 and Does Not Alter the Recognition of Autologous Melanoma Antigens , 2003, The Journal of Immunology.

[13]  David J. Cole,et al.  CD8-Independent Tumor Cell Recognition Is a Property of the T Cell Receptor and Not the T Cell 1 , 2003, The Journal of Immunology.

[14]  Urs Christen,et al.  CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes , 2003, Nature.

[15]  David Baltimore,et al.  Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors , 2002, Science.

[16]  T. Schumacher,et al.  Immunotherapy through TCR gene transfer , 2001, Nature Immunology.

[17]  D. Haas,et al.  Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[18]  R. Schreiber,et al.  CD4+ T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-γ , 1999 .

[19]  S. Rosenberg,et al.  Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity. , 1999, Journal of immunology.

[20]  C. Lowenstein,et al.  The Central Role of CD4+ T Cells in the Antitumor Immune Response , 1998, The Journal of experimental medicine.

[21]  D. Pardoll,et al.  The role of CD4+ T cell responses in antitumor immunity. , 1998, Current opinion in immunology.

[22]  J. Forman,et al.  Helper activity is required for the in vivo generation of cytotoxic T lymphocytes , 1982, The Journal of experimental medicine.

[23]  R. Debets,et al.  Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR αβ gene transfer requires CD8α , 2005, Gene Therapy.

[24]  M. Nishimura,et al.  Simultaneous Generation of CD 8 + and CD 4 + Melanoma-Reactive T Cells by Retroviral-Mediated Transfer of a Single T-Cell Receptor , 2005 .

[25]  K. Cornetta,et al.  Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods , 2002, Gene Therapy.